Extending a Bold vision for Longevity

After making a handful of longevity-related investments as a partner at Bold Capital, Sergey Young is seeking to invest about $100 million via the Longevity Vision Fund, a new vehicle dedicated solely to the field of life extension technologies.

Young told BioCentury the fund has raised $50 million in its initial close and is seeking to double that amount for a final close, although the final total could be as high as $125 million...